September 2015 FDA Recall Drug by Valeant Pharmaceuticals North America Llc
D-0163-2016 - Failed Dissolution Specifications

This Class II drug recall was voluntarily initiated by Valeant Pharmaceuticals North America Llc on September 4, 2015 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0163-2016

Reason for Recall
Failed Dissolution Specifications: Failed 24 month dissolution testing.
Initiated
09-04-2015
Reported
11-11-2015
Quantity
3341 Bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Valeant Pharmaceuticals North America LLC
Fenoglide (fenofibrate) tablets, 120 mg Tablets, 90 Ct Bottle, Rx Only. Distributed by: Santarus, Inc. San Diego, CA 92130. NDC: 68012-495-90.

Batch or Lot Expiration Information

Lot# 1300939, Expiry: March 2016.